SCHEMBL4132665

SCHEMBL4132665

COC(=O)c1ccc(-c2cc(C)c(OCC=O)c(C)c2)cc1C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMKK2 Q96RR4 5/20 0.37
CAMKK1 Q8N5S9 3/20 0.37
TDP1 Q9NUW8 1/20 0.35
SRD5A2 P31213 1/20 0.34
MCHR1 Q99705 1/20 0.33
MAPK8 P45983 2/20 0.32
PIK3CG P48736 2/20 0.32
GSK3B P49841 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
MCL1 Q07820 1/20 0.32
HPGD P15428 1/20 0.32
LMNA P02545 1/20 0.32
ERN1 O75460 1/20 0.32
PRF1 P14222 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3189644 0.85 SRD5A2 (0.40) CAMKK2CAMKK1TDP1SRD5A2MCHR1
SCHEMBL4142314 0.82 HMGCR (0.42) KDM4E
SCHEMBL4146025 0.82 MCL1 (0.49) ALDH1A1MCL1HPGDLMNA
SCHEMBL4147518 0.81 VDR (0.35) CAMKK2CAMKK1TDP1SRD5A2MCHR1
SCHEMBL4133314 0.80 CA1 (0.41) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL4816375 0.75 GAA (0.43) CAMKK2CAMKK1SRD5A2ALDH1A1LMNA
SCHEMBL3198759 0.74 HIF1A (0.47) SLC6A2SLC6A4SLC6A3LMNA
SCHEMBL3198748 0.74 HIF1A (0.47) SLC6A2SLC6A4SLC6A3LMNA
SCHEMBL4815035 0.72 MAPT (0.44) CAMKK2CAMKK1TDP1KDM4E
SCHEMBL4133504 0.71 MCL1 (0.58) CAMKK2CAMKK1MAPK8PIK3CGGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090030218-A1 Method For Producing Aminoalcohol Derivative Having Biphenyl Group KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-01-29 US disclosed
US-20090030218-A1 Method For Producing Aminoalcohol Derivative Having Biphenyl Group KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-01-29 US disclosed
US-20090030218-A1 Method For Producing Aminoalcohol Derivative Having Biphenyl Group KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-01-29 US disclosed
EP-1932826-A1 METHOD FOR PRODUCING AMINOALCOHOL DERIVATIVE HAVING BIPHENYL GROUP Kissei Pharmaceutical Co., Ltd. (JP) 2008-06-18 EP disclosed
EP-1932826-A1 METHOD FOR PRODUCING AMINOALCOHOL DERIVATIVE HAVING BIPHENYL GROUP Kissei Pharmaceutical Co., Ltd. (JP) 2008-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030218-A1 Method For Producing Aminoalcohol Derivative Having Biphenyl Group ALDH7A1, DDC, ADH5 CAMKK2 4864/4885CAMKK1 4881/4885TDP1 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.